New insights into the cellular and molecular mechanisms of absence seizures

Bochum researchers have gained new insights into the cellular and molecular mechanisms of absence seizures and potential therapy options.

Stimulation of certain cerebellar areas could help combat absence seizures. However, what happens at the cellular and molecular level in the brain in this form of epilepsy and how exactly stimulation has an effect is not yet understood in detail. Researchers at Ruhr-Universität Bochum (RUB) have gained new insights by conducting experiments with mice. The team led by Dr. Jan Claudius Schwitalla and Professor Melanie Mark from the RUB Behavioral Neuroscience research group describes the results in the journal "Cellular and Molecular Life Sciences" from 19 March 2022. They cooperated with the Erasmus Medical Center in Rotterdam and Utrecht as well as with colleagues from Bonn, Münster and München.

Abrupt loss of consciousness

More than 1.5 million people worldwide suffer from absence seizures, also known as petit mal seizures. Patients experience an abrupt loss of consciousness and lapse into a paralysis of behavior that lasts for a few seconds. Absence seizures often occur in children between the ages of four and twelve and are often mistaken for daydreaming. They are linked to altered brain activity, which is visible in brain activity recordings as so-called spike-and-wave discharges (SWDs). The characteristic activity pattern originates from the rhythmic and synchronized activity of nerve cells in the cerebral cortex and thalamus.

Since the nuclei located deep in the cerebellum have a widespread connectivity to various regions of the brain, researchers proposed that it might be possible to treat seizures by stimulating the cerebellar nuclei. Experiments with rodents by other research groups showed that such stimulation can indeed stop absence seizures. However, it is unclear what underlies this effect at the cellular and molecular level.

Cerebellar stimulation against abnormal brain activity

The Bochum-based researchers worked with mice that develop absence seizures due to a lack of the P/Q-type calcium channel in nerve cells of the cerebellum. They found that cells of the cerebellar nuclei were firing abnormally, and that stimulation of these cells could prevent further SWDs. Therefore, they stimulated the cerebellar nuclei by administering a pharmacological substance or via chemogenetic stimulation. For chemogenetic stimulation, a genetically modified receptor is introduced into cells so that they can be activated by a specifically designed molecule normally not present in the brain. This allowed the researchers to slowly increase the activity of the cerebellar nuclei cells and thus prevent the occurrence of further SWDs in mice.

Furthermore, the team used optogenetic stimulation to briefly increase the activity of cells in the cerebellar nuclei and to stop on-going SWDs after they have started. This technique uses proteins from algae that can be turned on by light to increase the activity of nerve cells. Overall, the study confirmed that targeted stimulation of the cerebellar nuclei could become a therapeutic approach for people suffering from absence seizures.

Source:
Journal reference:

Schwitalla, J.C., et al. (2022) Controlling absence seizures from the cerebellar nuclei via activation of the Gq signaling pathway. Cellular and Molecular Life Sciences. doi.org/10.1007/s00018-022-04221-5.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New research explores how antimicrobial exposure affects Parkinson’s disease risk